180
Participants
Start Date
May 16, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
March 31, 2027
Tibulizumab Dose A
Anti BAFF/IL-17 antibody. ZB-106
Tibulizumab Dose B
Anti BAFF/IL-17 antibody. ZB-106
Placebo
ZB-106 Placebo
RECRUITING
Equity Medical, New York
RECRUITING
Gregorio Marañón General University Hospital, Madrid
RECRUITING
DelRicht Research, Mt. Pleasant
RECRUITING
Palmetto Clinical Trial Services, Anderson
RECRUITING
Georgia Skin & Cancer Clinic, Savannah
RECRUITING
Florida Academic Dermatology Center, Coral Gables
RECRUITING
International Clinical Research - Tennessee LLC, Murfreesboro
RECRUITING
DS Research of Kentucky, LLC, Louisville
RECRUITING
Equity Medical LLC (Kentucky), Bowling Green
RECRUITING
ClinOhio Research Services, Columbus
RECRUITING
Apex Clinical Research Center, Mayfield Heights
RECRUITING
Optima Research, Boardman
RECRUITING
The Indiana Clinical Trials Center, Plainfield
RECRUITING
MediSearch Clinical Trials, Saint Joseph
RECRUITING
Clinical Trials Management, LLC, Metairie
RECRUITING
DelRicht LLC, Baton Rouge
RECRUITING
DelRicht Research, Prosper
RECRUITING
BRCR Global Texas, Katy
RECRUITING
Progressive Clinical Research, San Antonio
RECRUITING
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp z .o.o, Malbork
RECRUITING
Medical Dermatology Specialists (Phoenix), Phoenix
RECRUITING
Skin Cancer and Dermatology Institute, Sparks
RECRUITING
Wallace Medical Group, Inc., Los Angeles
RECRUITING
First OC Dermatology Research, Inc., Irvine
RECRUITING
NorCal Clinical Research, Rocklin
RECRUITING
University of Washington Medical Center, Seattle
RECRUITING
Dermatology Specialists of Spokane, Spokane
RECRUITING
Ryan Clinical Research Inc., Newmarket
RECRUITING
Centre de recherche Saint-Louis, Québec
RECRUITING
Saskatoon Dermatology Centre, Saskatoon
RECRUITING
Provita Sp. z o. o., Katowice
RECRUITING
Laser Clinic S.C., Szczecin
Zura Bio Inc
INDUSTRY